Nerve Repair and Regeneration Market by Product, Application, and Geography - Forecast and Analysis 2023-2027

Published: Nov 2022 Pages: 153 SKU: IRTNTR74728

The global nerve repair and regeneration market size is estimated to grow by USD  4,891.9 million between 2022 and 2027 accelerating at a CAGR of 11.23%

This nerve repair and regeneration market report extensively covers market segmentation by Product (neuromodulation devices and biomaterials), Application (neurorrhaphy, nerve grafting, and stem cell therapy), and Geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. 

The growth of the market depends on several factors, including the rising prevalence of neurological disorders, increasing government funds for research on neurological diseases, and expansion of neurology-related research projects.

Nerve Repair And Regeneration Market Overview:

 View the Bestselling Market Research Sample 

Nerve Repair And Regeneration Market Covid Recovery Analysis:

COVID-19 negatively impacted the regional nerve repair and regeneration market in 2020 due to disruptions in the healthcare industry's supply chain. Government measures such as business closures and travel restrictions resulted in a decline in demand for non-urgent pharmaceutical operations, including nerve therapies. However, with the availability of COVID-19 vaccines and the relaxation of lockdown measures, clinics, and hospitals resumed nerve repair and regeneration procedures in mid-2021, increasing the demand for neurostimulation devices. Additionally, the market's growth during the forecast period is fueled by an increase in Alzheimer's and dementia cases in the region.

Nerve Repair And Regeneration Market: Key Drivers, Trends, Challenges

 Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Nerve Repair And Regeneration Market Driver

The nerve repair and regeneration market is expanding globally due to the increasing prevalence of neurological illnesses, particularly Alzheimer's disease, which is the leading cause of impairment. The aging population and rising number of nerve injuries are also contributing to market growth. Healthcare organizations worldwide are offering innovative solutions for the quick diagnosis and treatment of neurological illnesses. Nerve repair and regeneration replaces injured neural tissue and produces new axons, myelin, neurons, glial cells, and synapses. As the frequency of neurological disorders increases, the market is expected to continue expanding during the forecast period.

Significant Nerve Repair And Regeneration Market Trends

The nerve repair and regeneration market is expanding due to technological developments in stem cell therapy and neuromodulation devices. Endogenous stem cells are used in neurogenesis and neural repair, while clinical trials are underway to develop safe and effective treatments for neurological conditions. The market is also expected to grow due to rising healthcare spending and improvements in medical infrastructure, particularly in developing countries. Governments are investing in research, such as the Australian government's  USD 21.8 million for neurological conditions. Technological advancements will continue to drive the global nerve repair and regeneration market during the forecast period.

Major Nerve Repair And Regeneration Market Challenge

The nerve repair and regeneration market faces constraints such as a shortage of skilled specialists and tissue morbidity affecting donor nerves. Nerve conduits are limited to gaps smaller than 3 cm, and devices for neurostimulation and neuromodulation may require premarket approval. The World Health Organization estimates a shortage of health professionals with digital technological skills. The COVID-19 pandemic has diverted healthcare resources from other diseases, including neurological conditions. These challenges will hinder the growth of the global nerve repair and regeneration market during the forecast period.

Who are the Major Nerve Repair and Regeneration Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company offers solutions for nerve repair regeneration by eliminating the time required for harvesting an autograft using modern technology. Under this segment, the company also offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation. Additionally, Under the diagnostic segment, the company focuses on core laboratory, molecular solutions, point-of-care solutions, and rapid diagnostics.

The report also includes detailed analyses of the competitive landscape of the market and information about prominent and key market vendors, including:

  • ALEVA NEUROTHERAPEUTICS SA
  • AxoGen Inc.
  • Baxter International Inc.
  • BioWaveGO USA
  • Boston Scientific Corp.
  • Check Point Surgical Inc.
  • Collagen Matrix Inc.
  • Gimer Medical Co. Ltd.
  • Integra Lifesciences Holdings Corp.
  • KeriMedical SA
  • LivaNova Plc
  • Medtronic Plc
  • NEURONETICS Inc.
  • NeuroPace Inc.
  • NeuroSigma Inc.
  • Polyganics BV
  • Soterix Medical Inc.
  • Stryker Corp.
  • Synapse Biomedical Inc.

Technavio’s report consists of a holistic analysis of the key development analysis,  development stage, key market players, their marketing strategies, and powerful innovations to help any client gain a competitive edge.  

Nerve Repair And Regeneration Market Segmentation by Product, Application, Geography

Product Analysis

The market share growth of the neuromodulation device segment will be significant during the forecast period. Neuromodulation is a technique that targets nerve injury by sending electrical impulses to the affected area. Neuromodulation surgical devices are well-known in the healthcare industry and have a high market share. The supply chain interruptions induced by the pandemic had a significant influence on neuromodulation devices, which had a positive impact on the demand for neuromodulation surgery devices across the world in 2020. 

Get a detailed analysis of various segments View Sample PDF 

Application Analysis

Direct repair, also known as neurorrhaphy, is used when the injured ends of a nerve may be matched without effort. Excessive strain at the coaptation location is known to be harmful to nerve vascularity and functional result. As nerves are elastic, a certain amount of stress is to be expected in most repairs. When the tension at the coaptation site cannot be sustained by a single 8-0 suture, nerve grafting is often advised. The neurorrhaphy segment holds a considerable amount of market share and is expected to grow during the forecast period owing to the rapid evolution in neurotechnology and emerging promising therapies for various neurological disorders.

Geographical Analysis

For more insights on the market share of various regions View PDF Sample now!

North America is projected to contribute 32% by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The US is the major contributor to the nerve repair and regeneration market in North America, owing to the rising capital expenditure on treating patients with neurological disorders such as epilepsy and dementia and the growing demand for neuromodulation devices. According to the Annals of Neurology, neurological disorders exert a financial burden on the healthcare system in the US, which accounts for spending approximately $800 billion every year. The increasing number of patients with neurological disorders and the increasing cost of treatment in the US are expected to boost market growth during the forecast period. The high fiscal healthcare expenditure and advanced healthcare infrastructure are significant contributors to regional market growth.

 

Nerve Repair And Regeneration Market Scope

Report Coverage

Details

Page number

120

Base year

2022

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 11.23%

Market growth 2023-2027

USD 4,891.9 million

Market structure

Fragmented

YoY growth (%)

10.89

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 32%

Key consumer countries

US, Canada, Germany, China, Japan, and India

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, AxoGen Inc., Baxter International Inc., BioWaveGO USA, Boston Scientific Corp., Check Point Surgical Inc., Collagen Matrix Inc., Gimer Medical Co. Ltd., Integra Lifesciences Holdings Corp., KeriMedical SA, LivaNova Plc, Medtronic Plc, NEURONETICS Inc., NeuroPace Inc., NeuroSigma Inc., Polyganics BV, Soterix Medical Inc., Stryker Corp., and Synapse Biomedical Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF sample

What are the Key Data Covered in this Nerve Repair And Regeneration Market Report?

  • CAGR of the market during the forecast period 2023-2027
  • Detailed information on factors that will drive nerve repair and regeneration market growth during the next five years
  • Precise estimation of the nerve repair and regeneration market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the nerve repair and regeneration market industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of nerve repair and regeneration market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global nerve repair and regeneration market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global nerve repair and regeneration market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Neuromodulation devices - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Neuromodulation devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Neuromodulation devices - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Neuromodulation devices - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Neuromodulation devices - Year-over-year growth 2022-2027 (%)
    • 6.4 Biomaterials - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Biomaterials - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Biomaterials - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Biomaterials - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Biomaterials - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 43: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Application - Market share 2022-2027 (%)
    • 7.2 Comparison by Application
      • Exhibit 45: Chart on Comparison by Application
      • Exhibit 46: Data Table on Comparison by Application
    • 7.3 Neurorrhaphy - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Neurorrhaphy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on Neurorrhaphy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on Neurorrhaphy - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Neurorrhaphy - Year-over-year growth 2022-2027 (%)
    • 7.4 Nerve grafting - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Nerve grafting - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on Nerve grafting - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on Nerve grafting - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Nerve grafting - Year-over-year growth 2022-2027 (%)
    • 7.5 Stem cell therapy - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Stem cell therapy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Stem cell therapy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Stem cell therapy - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Stem cell therapy - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Application
      • Exhibit 59: Market opportunity by Application ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 63: Chart on Geographic comparison
      • Exhibit 64: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 India - Market size and forecast 2022-2027
      • Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)
    • 9.13 Market opportunity by geography
      • Exhibit 105: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 108: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 109: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 110: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 111: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 112: Abbott Laboratories - Overview
              • Exhibit 113: Abbott Laboratories - Business segments
              • Exhibit 114: Abbott Laboratories - Key news
              • Exhibit 115: Abbott Laboratories - Key offerings
              • Exhibit 116: Abbott Laboratories - Segment focus
            • 12.4 ALEVA NEUROTHERAPEUTICS SA
              • Exhibit 117: ALEVA NEUROTHERAPEUTICS SA - Overview
              • Exhibit 118: ALEVA NEUROTHERAPEUTICS SA - Product / Service
              • Exhibit 119: ALEVA NEUROTHERAPEUTICS SA - Key offerings
            • 12.5 AxoGen Inc.
              • Exhibit 120: AxoGen Inc. - Overview
              • Exhibit 121: AxoGen Inc. - Product / Service
              • Exhibit 122: AxoGen Inc. - Key offerings
            • 12.6 Baxter International Inc.
              • Exhibit 123: Baxter International Inc. - Overview
              • Exhibit 124: Baxter International Inc. - Business segments
              • Exhibit 125: Baxter International Inc. - Key news
              • Exhibit 126: Baxter International Inc. - Key offerings
              • Exhibit 127: Baxter International Inc. - Segment focus
            • 12.7 Boston Scientific Corp.
              • Exhibit 128: Boston Scientific Corp. - Overview
              • Exhibit 129: Boston Scientific Corp. - Business segments
              • Exhibit 130: Boston Scientific Corp. - Key news
              • Exhibit 131: Boston Scientific Corp. - Key offerings
              • Exhibit 132: Boston Scientific Corp. - Segment focus
            • 12.8 Collagen Matrix Inc.
              • Exhibit 133: Collagen Matrix Inc. - Overview
              • Exhibit 134: Collagen Matrix Inc. - Product / Service
              • Exhibit 135: Collagen Matrix Inc. - Key offerings
            • 12.9 Integra Lifesciences Holdings Corp.
              • Exhibit 136: Integra Lifesciences Holdings Corp. - Overview
              • Exhibit 137: Integra Lifesciences Holdings Corp. - Business segments
              • Exhibit 138: Integra Lifesciences Holdings Corp. - Key news
              • Exhibit 139: Integra Lifesciences Holdings Corp. - Key offerings
              • Exhibit 140: Integra Lifesciences Holdings Corp. - Segment focus
            • 12.10 LivaNova Plc
              • Exhibit 141: LivaNova Plc - Overview
              • Exhibit 142: LivaNova Plc - Business segments
              • Exhibit 143: LivaNova Plc - Key offerings
              • Exhibit 144: LivaNova Plc - Segment focus
            • 12.11 Medtronic Plc
              • Exhibit 145: Medtronic Plc - Overview
              • Exhibit 146: Medtronic Plc - Business segments
              • Exhibit 147: Medtronic Plc - Key news
              • Exhibit 148: Medtronic Plc - Key offerings
              • Exhibit 149: Medtronic Plc - Segment focus
            • 12.12 NEURONETICS Inc.
              • Exhibit 150: NEURONETICS Inc. - Overview
              • Exhibit 151: NEURONETICS Inc. - Product / Service
              • Exhibit 152: NEURONETICS Inc. - Key offerings
            • 12.13 NeuroPace Inc.
              • Exhibit 153: NeuroPace Inc. - Overview
              • Exhibit 154: NeuroPace Inc. - Product / Service
              • Exhibit 155: NeuroPace Inc. - Key offerings
            • 12.14 Polyganics BV
              • Exhibit 156: Polyganics BV - Overview
              • Exhibit 157: Polyganics BV - Product / Service
              • Exhibit 158: Polyganics BV - Key offerings
            • 12.15 Soterix Medical Inc.
              • Exhibit 159: Soterix Medical Inc. - Overview
              • Exhibit 160: Soterix Medical Inc. - Product / Service
              • Exhibit 161: Soterix Medical Inc. - Key offerings
            • 12.16 Stryker Corp.
              • Exhibit 162: Stryker Corp. - Overview
              • Exhibit 163: Stryker Corp. - Business segments
              • Exhibit 164: Stryker Corp. - Key news
              • Exhibit 165: Stryker Corp. - Key offerings
              • Exhibit 166: Stryker Corp. - Segment focus
            • 12.17 Synapse Biomedical Inc.
              • Exhibit 167: Synapse Biomedical Inc. - Overview
              • Exhibit 168: Synapse Biomedical Inc. - Product / Service
              • Exhibit 169: Synapse Biomedical Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 170: Inclusions checklist
                • Exhibit 171: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 172: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 173: Research methodology
                • Exhibit 174: Validation techniques employed for market sizing
                • Exhibit 175: Information sources
              • 13.5 List of abbreviations
                • Exhibit 176: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              nerve repair and regeneration market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis